Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/22/2001 | WO2001019976A3 Plant regulatory sequences for control of gene expression |
11/22/2001 | WO2001014564A3 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
11/22/2001 | WO2001007637B1 Conditionally controlled, attenuated hiv vaccine |
11/22/2001 | WO2000070089A9 Cdx2 is downstream mediator of apc tumor suppressor activity |
11/22/2001 | WO2000070022A9 Ex vivo expansion of mammalian hematopoietic stem cells |
11/22/2001 | US20010044937 Transgenic intracytoplasmic sperm injection, retroviral gene transfer, intracytoplasmic nuclear injection, and pronuclear injection; useful as models for human disease/diagnosis, assessing safety and efficiency of drug and gene therapy |
11/22/2001 | US20010044525 Fibroblast growth factor (FGF); antibodies, expression vectors, fusion proteins; culturing mesenchymal stem cells or progenitor cells in presence of zFGF12 to stimulate cell proliferation |
11/22/2001 | US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells |
11/22/2001 | US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants |
11/22/2001 | US20010044436 Bicyclic inhibitors of glycogen synthase kinase 3 |
11/22/2001 | US20010044150 Method for transformation of animal cells |
11/22/2001 | US20010044149 Transfer of heterologous gene sequences into cells using equine infectious anemia virus-derived vectors for gene delivery |
11/22/2001 | US20010044148 EBV-infected stomach cancer cell line |
11/22/2001 | US20010044146 Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
11/22/2001 | US20010044144 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
11/22/2001 | US20010044122 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
11/22/2001 | US20010044100 Messenger RNA is used as a target (marker) which exists mainly on float in the cytoplasm and is a transcriptional product of a gene instead of using the translation product. |
11/22/2001 | US20010043922 Recombinants of the multiply deficient adenoviral vectors; a therapeutic method and their use particularly relating to gene therapy and vaccination |
11/22/2001 | US20010043921 A retroviral vector of a heterologous nucleic acid sequence as well as at least one sequence allowing site-specific integration of the sequence into a non-coding region of a genome; gene therapy of genetic defects; viricides |
11/22/2001 | US20010043919 Proliferation of hepatocyte precursors |
11/22/2001 | US20010043918 Biosynthesis of a musculoskeletal tissue, e.g., bone, cartilage and ligaments, by placing the precursor, e.g. osteoblasts, in a culture vessel and applying at least one force on the tissue to respond to a desired physical property |
11/22/2001 | CA2410181A1 Novel motor proteins and methods for their use |
11/22/2001 | CA2409746A1 Immunotoxin fusion proteins and means for expression thereof |
11/22/2001 | CA2409703A1 Novel differentiation inducing process of embryonic stem cell to ectodermal cell and its use |
11/22/2001 | CA2409506A1 Method for cell adhesion and wound healing |
11/22/2001 | CA2409452A1 Methods for enriching for quiescent cells in hematopoietic cell populations |
11/22/2001 | CA2409448A1 Methods for modulating the proliferation of hematopoietic cells |
11/22/2001 | CA2409414A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
11/22/2001 | CA2409361A1 Humanised antibodies to the epidermal growth factor receptor |
11/22/2001 | CA2409148A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
11/22/2001 | CA2409141A1 Method for preventing allograft rejection |
11/22/2001 | CA2409108A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
11/22/2001 | CA2409102A1 Microinjection of cryoprotectants for preservation of cells |
11/22/2001 | CA2409077A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
11/22/2001 | CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators |
11/22/2001 | CA2409031A1 Insecticidal secreted proteins of brevibacillus laterosporus |
11/22/2001 | CA2408830A1 Treatment of human papillomavirus (hpv)-infected cells |
11/22/2001 | CA2408756A1 Immune potentiating compositions |
11/22/2001 | CA2408745A1 Anti-angiogenic polypeptides |
11/22/2001 | CA2408701A1 Compositions and methods for tissue dedifferentiation and regeneration |
11/22/2001 | CA2408691A1 Compositions and methods for achieving immune suppression |
11/22/2001 | CA2408530A1 Novel deoxynucleoside kinase enzyme variants |
11/22/2001 | CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides |
11/22/2001 | CA2408503A1 Seven transmembrane proteins and polynucleotides encoding the same |
11/22/2001 | CA2408433A1 Synthetic gagpol genes and their uses |
11/22/2001 | CA2408374A1 Mutation in the .beta.2 nicotinic acetylcholine receptor subunit associated with nocturnal frontal lobe epilepsy |
11/22/2001 | CA2408360A1 Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
11/22/2001 | CA2408351A1 Lipid bilayer array methods and devices |
11/22/2001 | CA2408246A1 Cell line for the expression of an .alpha.2.delta.2 calcium channel subunit |
11/22/2001 | CA2408134A1 G-protein coupled receptors |
11/22/2001 | CA2407104A1 Method to increase class i presentation of exogenous antigens by human dendritic cells |
11/22/2001 | CA2404822A1 Fertilization of aged oocytes |
11/22/2001 | CA2398979A1 Novel bee venom polypeptides and methods of use thereof |
11/21/2001 | EP1156123A1 Method for detecting a variation of GH1 as indicator of growth hormone dysfunction |
11/21/2001 | EP1156117A2 Methods for isolating modulators of carotenoid biosynthesis enzymes |
11/21/2001 | EP1156116A1 Nucleotide sequences coding for signal transduction components involved in plant pathogen defense |
11/21/2001 | EP1156112A1 Synthetic gagpol genes and their uses |
11/21/2001 | EP1156111A1 Chimeric arterivirus-like particles |
11/21/2001 | EP1156110A2 G-protein coupled receptor (HFGAN72Y) |
11/21/2001 | EP1156106A1 Novel enzyme having decoloring activity and method for decoloring dyes by using the same |
11/21/2001 | EP1156064A2 Cat-mouse chimeric antibody directed to feline diseases and corresponding heterohydridoma |
11/21/2001 | EP1156037A1 Chondrongenesis promotors and indolin-2-one derivatives |
11/21/2001 | EP1155700A2 Lymphocyte chemoattractant factor and uses thereof |
11/21/2001 | EP1155136A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity |
11/21/2001 | EP1155134A1 Dna encoding a plant lipase, transgenic plants and a method for controlling senescence in plants |
11/21/2001 | EP1155131A2 Compositions and methods for non-targeted activation of endogenous genes |
11/21/2001 | EP1155130A2 Glucose dehydrogenase fusion proteins and their utilization in expression systems |
11/21/2001 | EP1155118A2 Pluripotential cells derived from embryonal teratocarcinoma cells and the nucleus of somatic cells |
11/21/2001 | EP1155116A1 Use of collagenase in the preparation of neural stem cell cultures |
11/21/2001 | EP1155115A1 Method of modifying cytotoxic cells and uses thereof |
11/21/2001 | EP1155114A1 Avian pluripotent embryonic germ cell line |
11/21/2001 | EP1155030A1 Novel component of von hippel-lindau tumor suppressor complex and scf ubiquitin ligase |
11/21/2001 | EP1155028A1 Pigment protein from coral tissue |
11/21/2001 | EP1154801A1 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
11/21/2001 | EP1154797A2 Multi-mutant diphtheria toxin vaccines |
11/21/2001 | EP1154788A1 Inhibitors of separin, method for identifying them and uses |
11/21/2001 | EP1154786A2 Methods and compositions for altering mucus secretion |
11/21/2001 | EP1154780A2 Bone marrow transplantation for hepatic regeneration and repair |
11/21/2001 | EP1154692A1 A method of controlling fungal pathogens, and agents useful for same |
11/21/2001 | EP1154686A1 Method for inhibiting transplant rejection |
11/21/2001 | EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
11/21/2001 | EP0773962B1 Antibodies which activate an erythropoietin receptor |
11/21/2001 | EP0767676B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
11/21/2001 | EP0765168B1 Combination of a procoagulant and a cytokine or an inducer of cytokine production for the treatment of tumors |
11/21/2001 | EP0742902B1 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
11/21/2001 | EP0536186B1 Bone and cartilage inductive proteins |
11/21/2001 | CN1323354A Characterisation of gene function using double stranded RNA inhibition |
11/21/2001 | CN1323350A Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
11/21/2001 | CN1323349A Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof |
11/21/2001 | CN1323348A Delivery system for porcine somatotropin |
11/21/2001 | CN1323347A Means and methods for modulating stomata characteristica in plants |
11/21/2001 | CN1323346A TPL-2/COT kinase and methods of use |
11/21/2001 | CN1323181A Method and device for preparing a dental implant by immersion in a mesenchymal cell culture |
11/21/2001 | CN1322816A Method of separating megakaryo archeocyte |
11/21/2001 | CN1322759A Composition for stimulating megacaryocyte growth and differentiation and process thereof |
11/21/2001 | CN1075078C Producing process of stem cell factor |
11/20/2001 | US6320103 Transgenic plants with intensified osmotolerance |
11/20/2001 | US6320100 Synthetic DNA sequences having enhanced insecticidal activity in maize |
11/20/2001 | US6320097 Nucleotide sequences for use as genetic engineering tools; for use in expression of heterologous proteins |
11/20/2001 | US6320038 Promoter for neuropeptide FF and use thereof for therapy and diagnostics |